Skip to search formSkip to main contentSkip to account menu

24 HR Nifedipine 30 MG Extended Release Oral Tablet

Known as: NIFEdipine 30 MG 24 HR Extended Release Oral Tablet, NIFEDIPINE (EQV-XL) 30MG SA TAB UD, NIFEDIPINE 30 mg ORAL TABLET, EXTENDED RELEASE [Nifedipine Extended-Release] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
This study was designed to determine the pattern of zygomatic bone fracture, etiology and treatment options. The term pattern in… 
2006
2006
Nifedipine (NIF), a 1,4-dihydropyridine calcium channel antagonist, undergoes photodegradation to dehydro-nifedipine (DNIF) upon… 
2005
2005
Aims. This post‐marketing surveillance study assessed the efficacy, safety, and tolerability of the treatment with nifedipine… 
2003
2003
It is well established that calcium is the trigger for fast action potential-evoked synaptic transmission (1). After elevation of… 
2000
2000
Aims: Short-acting calcium entry blockers should be used primarily in slow-release form. Furthermore, studies of the… 
1999
1999
1. The aim of the present study was to compare the efficacy of nifedipine Oros® and felodipine extended release (ER) in… 
1990
1990
1. The effects of dihydropyridine (DHP) derivatives on current through the slow Ca2+ channel and on isometric force were…